Radequinil

DB19722InvestigationalSmall molecule

Radequinil is a small molecule drug. The usage of the INN stem '-nil' in the name indicates that Radequinil is a benzodiazepine receptor antagonist/agonist. Radequinil is under investigation in clinical... Radequinil is under investigation in clinical trial NCT00359944 (Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease).

Chemical structure of Radequinil
Formula / weight
C18H14N4O3 · 334.335 g/mol (avg)
Code names
AC-3933

Resolves to

Compound
UNII2G222T03EYCAS219846-31-8ChEMBLCHEMBL2107801ChEBI752870PubChem135418404
Structure
InChIKeyJQOFKKWHXGQABB-UHFFFAOYSA-NSMILESCOC1=CC=CC(=C1)C1=C2C=C(C3=NOC(C)=N3)C(=O)NC2=CC=N1
Targets
Q99928GABRG3

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Radequinil, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In